Amendments in SION for export of Erythromycin Stearate Tablet
Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet – Public Notice No.46/2024-25
In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
| Export Product | Quantity | Si. No. | Import Item/s | Quantity |
| Erythromycin Stearate tablets-250 mg. (each tablet contains erythromycin stearatc equivalent to 250 mg. of Erythromycin | 1 Number Tablet | 1 | Erythromycin Stearate | 334 mg. |
Note: For other variants of export items, norms may be worked out on a pro-rata basis.
Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect.
Go to DGFT
Read More Updates on DGFT
